Abstract:Purpose: Remimazolam tosylate (HR-7056) is a novel ester-type benzodiazepine with ultrafast onset of effect. The compound is being developed for sedation induction and maintenance during anesthesia. It was approved for procedural anesthesia in December 2019 by the National Medical Products Administration of China. Previous studies have reported on remimazolam's effects on consciousness and cognition. Although the time to full psychomotor recovery after remimazolam-mediated sedation is critical for decisions regarding hospital discharge, relevant clinical evidence is still lacking. This study investigated the residual psychomotor effects of remimazolam and their recovery from sedating treatment in 2 simulated clinical settings: (1) single-dose administration for sedation initiation; and (2) constant rate infusion for sedation maintenance. Methods: A single-ascending-dose, parallel-group, midazolam-controlled study and a 2-way crossover study evaluating the reversal effect of flumazenil versus placebo after a 2-h constant rate infusion were conducted with HR-7056 in 87 Chinese healthy volunteers; the studies used a double-blind, randomized trial design. A battery of psychomotor tests was administered before dosing and several times postdose over 4-6 h. Pharmacokinetic, sedation, and safety assessments were performed throughout the studies. Findings: After bolus infusion, the Bispectral Index score decreased in a concentration-dependent manner with HR-7056, accompanied by a sharp drop of Modified Observer's Assessment of Alertness/Sedation score. The recovery of consciousness was much faster with HR-7056 than with midazolam. During the constant rate infusion, the Bispectral Index score was maintained between 40 and 60 with an average plasma remimazolam concentration of ~1000 ng/mL. Subjects' performance in saccadic and smooth pursuit eye movement, body sway, test of choice reaction time, and word recall was significantly impaired after single-dose midazolam and after constant rate infusion of remimazolam. The end-of-infusion injection of flumazenil shortened the median time to full alertness to 3.5 min and effectively reversed psychomotor and cardiovascular dysfunction. Implications: The study results showed quicker psychomotor recovery from sedation in the remimazolam-treated group. The moderate and short-lasting residual effect of remimazolam after 2-h conscious sedation proposes a need for psychomotor assessment(s) before hospital discharge. ClinicalTrials.gov identifiers: NCT01970072 and NCT03444480.

Potentiating effect of flunarizine on pentobarbital sleep

Potentiating Effect of Diltiazem on Pentobarbital-Induced Hypnosis is Augmented by Serotonergic System: the TMN and VLPO As Key Elements in the Pathway

Augmentative effect of tetrandrine on pentobarbital hypnosis mediated by 5-HT_(1A) and 5-HT_(2A/2C) receptors in mice

Ca2+ Modulation In Dorsal Raphe Plays An Important Role In Nrem And Rem Sleep Regulation During Pentobarbital Hypnosis

Diltiazem Potentiates Pentobarbital-Induced Hypnosis Via 5-HT1A and 5-HT2A/2C Receptors: Role for Dorsal Raphe Nucleus

Extract of Ganoderma Lucidum Potentiates Pentobarbital-Induced Sleep Via a GABAergic Mechanism

The Effect of Sevoflurane on the Cognitive Function of Rats and Its Association with the Inhibition of Synaptic Transmission.

Effect of sevoflurane on learning and memory and related mechanisms

Potentiating effect of spinosin, a C-glycoside flavonoid of Semen Ziziphi spinosae, on pentobarbital-induced sleep may be related to postsynaptic 5-HT1A receptors

Sleep-promoting Effect of L-Theanine on Mice

Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice.

Potentiation of the depressant effect of alcohol by flunitrazepam in rats: an electrocorticographic, respiratory and electrocardiographic study

The Hypnotic Synergism among a Water-Soluble Prodrug of Propofol,Midazolam and Fentanyl

Effect of flumazenil on bispectral index monitoring in unpremedicated patients

Augmentative Effect of Spinosin on Pentobarbital-Induced Loss of Righting Reflex in Mice Associated with Presynaptic 5-HT1A Receptor

Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex.

Tetrandrine, a Bisbenzylisoquinoline Alkaloid from Chinese Herb Radix, Augmented the Hypnotic Effect of Pentobarbital Through Serotonergic System.

Sevoflurane depresses neurons in the medial parabrachial nucleus by potentiating postsynaptic GABAA receptors and background potassium channels

The GABAA receptor modulator zolpidem augments hippocampal-prefrontal coupling during non-REM sleep

Pachymic Acid Enhances Pentobarbital-Induced Sleeping Behaviors via GABAA-ergic Systems in Mice

Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote